Dihydroergotamine Mesylate and Incruse Ellipta
Determining the interaction of Dihydroergotamine Mesylate and Incruse Ellipta and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dihydroergotamine
Brand name: DHE. 45, Migranal
Synonyms: Dihydroergotamine (injection), Dihydroergotamine
Generic Name: umeclidinium
Brand name: Incruse Ellipta
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dihydroergotamine Mesylate-Indacaterol
- Dihydroergotamine Mesylate-Indacaterol and Glycopyrrolate
- Dihydroergotamine Mesylate-Indacaterol and glycopyrrolate Inhalation
- Dihydroergotamine Mesylate-Indacaterol inhalation
- Dihydroergotamine Mesylate-Indacaterol Maleate
- Dihydroergotamine Mesylate-Indapamide
- Incruse Ellipta-Dihydroergotamine nasal
- Incruse Ellipta-Dihydroergotamine Nasal Spray
- Incruse Ellipta-Dilacor XR
- Incruse Ellipta-Dilantin
- Incruse Ellipta-Dilantin Infatabs
- Incruse Ellipta-Dilantin injection